Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Collegium Pharma (COLL)

Collegium Pharma (COLL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,575,492
  • Shares Outstanding, K 31,611
  • Annual Sales, $ 631,450 K
  • Annual Income, $ 69,190 K
  • EBIT $ 154 M
  • EBITDA $ 321 M
  • 60-Month Beta 0.61
  • Price/Sales 2.48
  • Price/Cash Flow 4.02
  • Price/Book 5.68

Options Overview Details

View History
  • Implied Volatility 53.12% (-2.56%)
  • Historical Volatility 19.75%
  • IV Percentile 33%
  • IV Rank 40.88%
  • IV High 81.84% on 10/06/25
  • IV Low 33.26% on 08/18/25
  • Expected Move (DTE 18) 4.40 (8.93%)
  • Put/Call Vol Ratio 0.06
  • Today's Volume 17
  • Volume Avg (30-Day) 15
  • Put/Call OI Ratio 0.17
  • Today's Open Interest 263
  • Open Int (30-Day) 361
  • Expected Range 44.93 to 53.73

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 2.03
  • Number of Estimates 3
  • High Estimate 2.08
  • Low Estimate 2.00
  • Prior Year 1.63
  • Growth Rate Est. (year over year) +24.54%

Price Performance

See More
Period Period Low Period High Performance
1-Month
45.82 +8.15%
on 12/02/25
50.79 -2.43%
on 12/29/25
+2.88 (+6.16%)
since 11/28/25
3-Month
31.26 +58.53%
on 10/13/25
50.79 -2.43%
on 12/29/25
+14.99 (+43.35%)
since 09/29/25
52-Week
23.23 +113.32%
on 04/10/25
50.79 -2.43%
on 12/29/25
+20.44 (+70.23%)
since 12/27/24

Most Recent Stories

More News
2 Reasons to Avoid COLL and 1 Stock to Buy Instead

2 Reasons to Avoid COLL and 1 Stock to Buy Instead

COLL : 49.62 (-0.44%)
3 Cash-Producing Stocks We Think Twice About

3 Cash-Producing Stocks We Think Twice About

COLL : 49.62 (-0.44%)
ROCK : 50.15 (-1.36%)
FUBO : 2.60 (-1.89%)
3 Unpopular Stocks We Find Risky

3 Unpopular Stocks We Find Risky

FCN : 175.69 (+0.11%)
COLL : 49.62 (-0.44%)
BK : 117.62 (+0.13%)
Branded Pharmaceuticals Stocks Q3 Recap: Benchmarking Collegium Pharmaceutical (NASDAQ:COLL)

Branded Pharmaceuticals Stocks Q3 Recap: Benchmarking Collegium Pharmaceutical (NASDAQ:COLL)

COLL : 49.62 (-0.44%)
1 Growth Stock Set to Flourishand 2 Facing Challenges

1 Growth Stock Set to Flourishand 2 Facing Challenges

COLL : 49.62 (-0.44%)
SBCF : 31.95 (-1.08%)
LOB : 34.71 (-1.42%)
1 Mooning Stock with Promising Prospects and 2 Facing Challenges

1 Mooning Stock with Promising Prospects and 2 Facing Challenges

COLL : 49.62 (-0.44%)
IRTC : 177.30 (+0.40%)
FBK : 57.03 (+0.39%)
1 Small-Cap Stock with Exciting Potential and 2 We Avoid

1 Small-Cap Stock with Exciting Potential and 2 We Avoid

COLL : 49.62 (-0.44%)
HIMS : 33.97 (-0.99%)
BOH : 69.34 (-0.91%)
5 Revealing Analyst Questions From Collegium Pharmaceutical’s Q3 Earnings Call

5 Revealing Analyst Questions From Collegium Pharmaceutical’s Q3 Earnings Call

COLL : 49.62 (-0.44%)
1 Safe-and-Steady Stock with Competitive Advantages and 2 We Brush Off

1 Safe-and-Steady Stock with Competitive Advantages and 2 We Brush Off

COLL : 49.62 (-0.44%)
VRTX : 458.36 (-0.98%)
ICFI : 88.36 (+2.53%)
Collegium to Participate in Upcoming Investor Conferences

STOUGHTON, Mass., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc.  (Nasdaq: COLL) today announced that its management will participate in the following investor conferences: Jefferies...

COLL : 49.62 (-0.44%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

Relative Strength just crossed below 70%. The market has dropped from overbought territory. Beware of a potential mean reversion.

See More Share

Business Summary

Collegium Pharmaceutical Inc. is a specialty pharmaceutical company. It develops and commercializes prescription and over-the-counter pharmaceuticals for the treatment of central nervous system, respiratory and skin related disorders. The Company's product candidate consists of COL-195, COL-196, COL-171,...

See More

Key Turning Points

3rd Resistance Point 51.12
2nd Resistance Point 50.57
1st Resistance Point 50.20
Last Price 49.62
1st Support Level 49.28
2nd Support Level 48.73
3rd Support Level 48.36

See More

52-Week High 50.79
Last Price 49.62
Fibonacci 61.8% 40.26
Fibonacci 50% 37.01
Fibonacci 38.2% 33.76
52-Week Low 23.23

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar